NEW YORK, June 7 - The proteomics market is expected to experience fivefold growth over the next four years, increasing from a $561-million market to a $2.8-billion market by 2005, Front Line Strategic Management Consulting said Thursday in a report.
NEW YORK, June 7 – In a continuing effort to position itself within the drug discovery arena, Sequenom on Thursday announced collaboration with German-based Morphochem to discover and develop drugs for type 2 diabetes and cancer treatment.
NEW YORK, June 7 – Bruker Daltonics will exclusively license MALDI-TOF mass spectrometry technology from Indiana University, and grant Applied Biosystems a sublicense to the technology, the companies said Thursday. The patented te
NEW YORK, June 7 - Roche scientists said Thursday that a new computational approach they have developed was applied successfully to identify regions of the mouse genome responsible for susceptibility to disease traits. The new app
NEW YORK, June 6 – Scientists at Structural Genomix published the structures of three proteins associated with bacterial virulence in Wednesday’s issue of the journal Structure, providing a detailed example of the company’s approach to solving protein struct
NEW YORK, June 6 - Luminex has licensed its LabMap technology to Research & Diagnostics systems, a company that specializes in assays for cytokines and related molecules, Luminex said Wednesday. Under the agreement, R&D
NEW YORK, June 6 – Genicon Sciences, a company that develops a light-based technology for development of biological interactions, announced Wednesday it had raised $5 million in a private financing, following on the heels of a $27 million financing
NEW YORK, June 6 - Orchid Biosciences said Wednesday it planned to sell $33.3 million worth of common stock to a number of private investors as part of an effort to shore up its cash reserves and launch new products.
This story has been updated from a previous version. NEW YORK, June 6 – Amersham Pharmacia Biotech announced Tuesday an agreement to supply their Ettan proteomics system to Dallas' Center for Biotechnology and Bioinf
NEW YORK, June 6 – In the first joint sale announced since their $5.5 million legal settlement, Genomic Solutions and PerkinElmer said Wednesday they had sold the GeneTac biochip system to the Indian Institute of Science in Bangalore, India.